CTS Corp banner

CTS Corp
Investor Relations

CTS Corp makes electronic components and sensors that help equipment measure, control, and connect signals. Its products include things like sensors, frequency control parts, and other precision components used inside larger systems rather than sold to consumers on their own. The company is mainly a parts supplier to industrial, automotive, aerospace, medical, and communications customers that need reliable components designed to fit specific technical requirements. CTS sells these parts to original equipment makers and other manufacturers that build them into finished products. It makes money by designing, manufacturing, and shipping these components, often in long-term supply relationships where customers depend on CTS for technical support, quality control, and consistent production. Because many of its products are engineered to customer specifications, the company is less of a commodity seller and more of a specialized supplier embedded in the customer’s design process. That role matters because CTS sits in the middle of the electronics value chain: it does not make finished cars, medical devices, or industrial machines, but it provides the sensing and control pieces those products need to work properly. This gives the business a mix of manufacturing know-how and engineering expertise, with demand tied to industries that need compact, dependable electronic parts.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Jul 28, 2026
AI Summary
Q2 2026

Revenue: CTS reported second-quarter sales of $145 million, up 7% year over year and 4% sequentially, with diversified end markets driving most of the growth.

Profitability: The company posted record gross margin of 41.5%, adjusted EBITDA margin of 25.4%, and adjusted diluted EPS of $0.74, though about $0.07 of EPS benefit came from unusual items.

Guidance: Management raised full-year 2026 guidance to sales of $565 million to $585 million and adjusted diluted EPS of $2.55 to $2.70, citing strong diversified demand and a cautious view on transportation.

Diversification: Diversified end markets made up 59% of sales, up from 55% a year ago, and management said this mix is central to its Evolution 2030 strategy.

Demand: Book-to-bill was 1.1 overall, with especially strong demand in medical at 1.21, aerospace and defense at 1.23, and industrial at 1.11.

Transportation: Transportation sales fell 2% year over year, but the company won about $163 million of new business and expects a modest second-half improvement in commercial vehicles.

Costs: Management said tariff, precious metal, and other input cost pressures are being actively negotiated with customers and suppliers, and they do not expect a material impact from the newest tariff announcements.

Key Financials
Sales
$145 million
Diversified end market sales
59% of total sales
Diversified end market sales growth
15% YoY
Transportation sales growth
down 2% YoY
Book-to-bill ratio
1.1
Diversified book-to-bill
1.17
Medical revenue
$28 million
Medical book-to-bill
1.21
Aerospace and defense revenue
$18 million
Aerospace and defense book-to-bill
1.23
Industrial revenue
$40 million
Industrial book-to-bill
1.11
Adjusted gross margin
41.5%
Adjusted EBITDA margin
25.4%
Adjusted diluted EPS
$0.74
EPS impact from unusual items
approximately $0.07
Operating cash flow
$33 million
Free cash flow
approximately $29 million
Cash balance
$108 million
Borrowings
$55 million
Share repurchases
approximately 64,000 shares for $3.5 million
Remaining buyback authorization
$78 million
Full-year tax rate
21% to 23%
Booked business
approximately $1.2 billion
Transportation new business awards
approximately $163 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Kieran M. O'Sullivan
Chairman, President & CEO
No Bio Available
Mr. Ashish Agrawal
VP, CFO & Principal Accounting Officer
No Bio Available
Mr. Scott L. D'Angelo
VP, General Counsel & Secretary
No Bio Available
Mr. Mitchell J. Walorski
Director of Investor Relations
No Bio Available
Pratik Trivedi
Senior Vice President
No Bio Available

Contacts

Address
ILLINOIS
Lisle
4925 Indiana Avenue
Contacts
+15745233800
www.ctscorp.com